{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:44:43Z","timestamp":1748493883745},"reference-count":63,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\/Aim: <\/jats:bold> Interleukin (IL\u201010) plays a major role in chronic hepatitis C virus (HCV) disease pathogenesis, in particular in <jats:italic>Schistosoma mansoni<\/jats:italic> (<jats:italic>S. mansoni<\/jats:italic>) co\u2010infected patients. Given that interindividual variations in IL\u201010 production are influenced by functional polymorphisms in the IL\u201010 gene promoter, we determined the frequencies of common (\u22121082, \u2212819 and \u2212592) IL\u201010 promoter polymorphisms in chronic HCV patients with and without <jats:italic>S. mansoni<\/jats:italic> co\u2010infection and healthy controls, and investigated their association with the degree of histological activity index (HAI) and response to interferon\u2013ribavirin therapy.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Genomic DNA from 99 patients and 62 healthy controls, born in the same geographical hyperendemic area, was studied by the polymerase chain reaction, followed by restriction enzyme digestion. Sera were assessed for <jats:italic>S. mansoni<\/jats:italic> antibodies.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The frequencies of IL\u201010 polymorphisms at positions \u22121082, \u2212819 and \u2212592 from the transcription start site were comparable between HCV patients and controls, as well as between HCV mono\u2010infected and either <jats:italic>S. mansoni<\/jats:italic> co\u2010infected patients or controls. The grade of inflammation and the stage of fibrosis showed no association with IL\u201010 polymorphisms. The frequencies of <jats:italic>S. mansoni<\/jats:italic> co\u2010infection and IL\u201010 genotypes\/haplotypes were insignificantly different between non\u2010responders and responders to combination therapy. No effect of other factors like age, gender, HAI group scores and serum alanine aminotransferase and aspartate aminotransferase levels was observed on response to therapy in our patients.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Our findings suggest that common IL\u201010 (\u22121082, \u2212819 and \u2212592) genotypes\/haplotypes do not influence the degree of HAI and response to combination therapy or susceptibility to HCV infection with and without <jats:italic>S. mansoni<\/jats:italic> co\u2010infection.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.02068.x","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T05:57:00Z","timestamp":1246859820000},"page":"1422-1430","source":"Crossref","is-referenced-by-count":20,"title":["Interleukin\u201010 promoter polymorphisms in hepatitis C patients with and without <i>Schistosoma mansoni<\/i> co\u2010infection"],"prefix":"10.1111","volume":"29","author":[{"given":"Omaima M.","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H.","family":"Abdel\u2010Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa M.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elamir M.","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_5_3_2","first-page":"915","article-title":"Liver disease in Egypt","volume":"43","author":"Strickland GT.","year":"2006","journal-title":"hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80419-5"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280332"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190205"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011629"},{"key":"e_1_2_5_8_2","first-page":"273A","article-title":"Cytokine profile defines different responses to interferon\u2010\u03b1 treatment in chronic hepatitis C infection","volume":"28","author":"Hussain MJ","year":"1998","journal-title":"Hepatology"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1992.tb01414.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70353-7"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i11.1681"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389201033489838"},{"key":"e_1_2_5_13_2","first-page":"483","article-title":"Immune modulation by helminthic infections","volume":"28","author":"Kamal SM","year":"2006","journal-title":"worms and viral infections"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21438"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.49.440"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.1991.45.743","article-title":"The impact of endemic schistosomiasis on acute viral hepatitis","volume":"45","author":"Ghaffar YA","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.4049\/jimmunol.148.10.3264","article-title":"Infection with Schistosoma mansoni alters Th1\/Th2 cytokine responses to a non\u2010parasite antigen","volume":"148","author":"Kullberg MC","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.3.948"},{"key":"e_1_2_5_19_2","first-page":"3050","article-title":"Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus","volume":"24","author":"Actor JK","year":"1994","journal-title":"association of viral persistence with egg granuloma formation"},{"key":"e_1_2_5_20_2","first-page":"1723","article-title":"Decreased atopy in children infected with Schistosoma haematobium","volume":"356","author":"Van Den Biggelaar AH","year":"2000","journal-title":"a role for parasite-induced interleukin-10"},{"key":"e_1_2_5_21_2","first-page":"6406","article-title":"IL\u201010 and the dangers of immune polarization","volume":"164","author":"Hoffmann KF","year":"2000","journal-title":"excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.010"},{"key":"e_1_2_5_23_2","first-page":"548","article-title":"DNA polymorphisms and response to treatment in patients with chronic hepatitis C","volume":"49","author":"Morgan TR","year":"2008","journal-title":"results from the HALT-C trial"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2007.01.007"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/498244"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-003-0594-5"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(03)00080-6"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2003.10.005"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00243-4"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300207"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2370.1997.tb00001.x"},{"key":"e_1_2_5_32_2","first-page":"185","article-title":"Cytokine (TNF alpha, LT alpha and IL\u201010) polymorphisms in inflammatory bowel diseases and normal controls","volume":"1","author":"Koss K","year":"2000","journal-title":"differential effects on production and allele frequencies"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20611.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310236"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80207-X"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1850"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200110270-00019"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2005.08.019"},{"issue":"2","key":"e_1_2_5_39_2","first-page":"S152","article-title":"Genetics of atopy and asthma","volume":"156","author":"Rosenwasser LJ","year":"1997","journal-title":"the rationale behind promoter-based candidate gene studies (IL-4 and IL-10)"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2"},{"key":"e_1_2_5_42_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2004.70.434","article-title":"Ethnic differences in polymorphisms of tumor necrosis factor\u2010alpha, interleukin\u201010, and transforming growth factor\u2010beta 1 genes in patients with chronic hepatitis C virus infection","volume":"70","author":"Zein NN","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.09.017"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240402"},{"key":"e_1_2_5_45_2","first-page":"449","article-title":"Detection of type 2\u2010like T\u2010helper cells in hepatitis C virus infection","volume":"25","author":"Tsai SL","year":"1997","journal-title":"implications for hepatitis C virus chronicity"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2009.01.019"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(06)80442-3"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i42.6656"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.00904.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22347"},{"key":"e_1_2_5_51_2","first-page":"404","article-title":"Interleukin\u20101, interleukin\u201010 and tumour necrosis factor\u2010alpha gene polymorphisms in hepatitis C virus infection","volume":"22","author":"Constantini PK","year":"2002","journal-title":"an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_5_54_2","first-page":"192","article-title":"Early prediction of response in interferon monotherapy and in interferon\u2013ribavirin combination therapy for chronic hepatitis C","volume":"30","author":"Brouwer JT","year":"1999","journal-title":"HCV RNA at 4 weeks versus ALT"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363920"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80093-2"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70217-4"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.2005.00762.x"},{"key":"e_1_2_5_59_2","first-page":"1371","article-title":"Hepatitis C genotype 4","volume":"47","author":"Kamal SM","year":"2008","journal-title":"what we know and what we don't yet know"},{"key":"e_1_2_5_60_2","first-page":"5692","article-title":"Treatment of hepatitis C virus genotype 4 with peginterferon alfa\u20102a","volume":"12","author":"Derbala MF","year":"2006","journal-title":"impact of bilharziasis and fibrosis stage"},{"key":"e_1_2_5_61_2","first-page":"472","article-title":"Combination treatment of interferon alpha\u20102b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients","volume":"31","author":"El\u2010Zayadi A","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"1","key":"e_1_2_5_62_2","first-page":"39","article-title":"Hepatitis C genotype 4 therapy","volume":"29","author":"Kamal SM.","year":"2009","journal-title":"increasing options and improving outcomes"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32672"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.10.007"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02068.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.02068.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:21:48Z","timestamp":1695936108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02068.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1478-3231.2009.02068.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02068.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}